Can Fite BioPharma : Immediate Report of Meeting : vimarsana

UNITED STATES


SECURITIES AND EXCHANGE COMMISSION


Washington, D.C. 20549


FORM 6-K


Report of...

Related Keywords

Washington , United States , Tel Aviv , Israel , Ramat Gan , Israeli , American , Pnina Fishman , Abraham Sartani , Yoseph Bornstein , Motti Farbstein , Kiryat Matalon , Kost Forer Gabbay Kasierer , Ilan Cohn , Securities Exchange , Israeli Securities Authority , American Depositary Shares Of The Company , Israeli Companies Law , Tel Aviv Stock Exchange , York Stock Exchange , New York Stock Exchange , Israel Companies Regulations Proof Of Ownership , Fite Biopharma Ltd , Company Compensation , Companies Law , Commission Public Reference Room , Exchange Commission , Commission File Number , Foreign Private Issuer Pursuant , Securities Exchange Act , Registration Statements , Can Fite Biopharma , Annual General Meeting , Gurion Street , Proxy Statement , Proxy Card , Voting Instruction Card , American Depositary Shares , Instruction Card , American Depositary Shareholders , Executive Officer , Chief Financial Officer , Can Fite Biopharma Ltd , General Meeting , Chief Executive , Compensation Policy , Kost Forer Gabbay , Young Global , Israel Companies Regulations , General Meetings , Chief Financial , American Depository Shares , Wednesday May , Deposit Agreement , New York Mellon , Record Shareholders , Beach Proposal , Proxy Materials , Annual Meeting , Exchange Act , Public Reference Room , Annual Report , Classi Directors , Classi Director , Guy Regev ,